DEBIO 1143, an IAP inhibitor, reverses ovarian cancer cells carboplatin resistance and triggers apoptotic or necroptotic cell death

BenoîtThibault¹, LudivineGenre¹, Augustin Le Naour¹, Clothilde Broca¹, Eliane Mery¹,
GrégoireVuagniaux², Jean Pierre Delord¹, NorbertWiedemann² & Bettina Couderc¹

Scientific Reportsvolume 8, Article number: 17862 (2018) 

 

1. Institut Claudius Regaud – IUCT Oncopole, University Toulouse III, Toulouse, France.
2. Debiopharm International SA, CH-1002, Lausanne, Switzerland.